Announcement on Voluntary Disclosure of Obtaining Approval Notice for Phase II Drug Clinical Trials of iza-bren (EGFR×HER3 Bispecific Antibody ADC) Combination Therapy in the Treatment of Various Advanced Renal Cell Carcinoma
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment